Adverse Event Reporting

VAERS ID 1151395
Gender Unknown
Age
StateCode TX
Pharmaceutical Company PFIZER\BIONTECH
Lot Number EL3249
Number of vaccinations 1
Vaccinated 2021-01-14
Onset 2021-01-14
Condition Permanent Disability Recovered
Symptoms
  • Arthralgia
  • Fatigue
  • Headache
  • Myalgia

Current Illness

Preexisting Conditions

Medical History/Concurrent Conditions: Arthritis; Cancer (Father, and sister); COPD (Sister); Discectomy (in the lower back); Fusion cervical spine; Heart disease, unspecified (Mother); Hypertension; Rotator cuff repair (right); Type 2 diabetes mellitus (Brother)

Other Medications

AMLODIPINE BESYLATE; METOPROLOL TARTRATE

Previous Vaccinations

Allergies

Laboratory Data

Write-up

fatigue; Joint pain/The joint and muscle pain I experience were primarily in my neck, shoulder elbows, wrist and fingers.
; sore musles/The joint and muscle pain I experience were primarily in my neck, shoulder elbows, wrist and fingers.
; headache; This is a spontaneous report from a contactable consumer.
A 75-year-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 intramuscular, administered in Arm Left on 14Jan2021 16:45 (Batch/Lot Number: EL3249) as SINGLE DOSE for covid-19 immunisation.
Medical history included hypertension, and had 2 surgeries 1) was a discectomy in the lower back and 2) in 2019, right rotator cuff surgery.
Prior to the surgeries, the patient suffered from arthritis that subsided following the surgeries and no longer take medications for the second surgery in 2017 was a cervical fusion of C2-3.
Family's medical history includes: Mother- heart disease, Father- Cancer, Sister- COPD- cancer, and Brother- Diabetes type 2.
Concomitant medications included amlodipine besylate; and metoprolol tartrate; taken for hypertension from unspecified start dates and ongoing.
On 14Jan2021 21:00, the patient experienced sore muscles/joint pain, and headache (extreme).
The joint and muscle pain the patient experienced were primarily in the patient's neck, shoulders, elbow, wrist and fingers.
On 15Jan2021, the patient experienced fatigue.
The events were assessed as serious (disability).
The patient did not receive treatment for the events.
The outcome of the events was recovered on 16Jan2021.
It was reported that the patient received second dose of bnt162b2 on 04Feb2021 12:45 (lot number: EL9265) in right arm via intramuscular.